Profile | GDS4284 / 204439_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 277.349 | 55 |
GSM687648 | Patient 402 control | 96.0924 | 35 |
GSM687653 | Patient 403 control | 743.533 | 70 |
GSM687658 | Patient 404 control | 12505.3 | 98 |
GSM687663 | Patient 411 control | 73.2501 | 27 |
GSM687668 | Patient 422 control | 432.752 | 62 |
GSM687673 | Patient 424 control | 6958.19 | 95 |
GSM687678 | Patient 425 control | 1125.61 | 75 |
GSM687683 | Patient 427 control | 1358.88 | 78 |
GSM687688 | Patient 428 control | 1267.44 | 77 |
GSM687695 | Patient 441 control | 2752.05 | 89 |
GSM687699 | Patient 443 control | 237.233 | 48 |
GSM687704 | Patient 444 control | 34.0737 | 18 |
GSM687707 | Patient 448 control | 1832.59 | 83 |
GSM687712 | Patient 449 control | 329.885 | 57 |
GSM687719 | Patient 450 control | 2474 | 87 |
GSM687724 | Patient 451 control | 1322.77 | 79 |
GSM687728 | Patient 452 control | 400.957 | 60 |
GSM687646 | Patient 401 treated 24h | 290.484 | 54 |
GSM687649 | Patient 402 treated 24h | 92.4634 | 35 |
GSM687665 | Patient 411 treated 24h | 149.122 | 40 |
GSM687651 | Patient 402 treated 4 weeks | 6.22637 | 2 |
GSM687667 | Patient 411 treated 4 weeks | 93.2171 | 32 |
GSM687670 | Patient 422 treated 24h | 612.632 | 66 |
GSM687671 | Patient 422 treated 4 weeks | 370.992 | 59 |
GSM687654 | Patient 403 treated 24h | 985.709 | 74 |
GSM687675 | Patient 424 treated 24h | 4067.84 | 92 |
GSM687685 | Patient 427 treated 24h | 1364.23 | 78 |
GSM687656 | Patient 403 treated 4 weeks | 535.342 | 65 |
GSM687677 | Patient 424 treated 4 weeks | 9884.44 | 97 |
GSM687687 | Patient 427 treated 4 weeks | 683.995 | 68 |
GSM687692 | Patient 428 treated 4h | 1922.73 | 83 |
GSM687716 | Patient 449 treated 4h | 307.743 | 57 |
GSM687722 | Patient 450 treated 4h | 2422.88 | 86 |
GSM687680 | Patient 425 treated 24h | 1152 | 76 |
GSM687690 | Patient 428 treated 24h | 1522.9 | 80 |
GSM687700 | Patient 443 treated 24h | 1856.55 | 83 |
GSM687705 | Patient 444 treated 24h | 71.3354 | 29 |
GSM687714 | Patient 449 treated 24h | 503.802 | 64 |
GSM687721 | Patient 450 treated 24h | 3512.62 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 1942.93 | 83 |
GSM687694 | Patient 428 treated 4 weeks | 1781.66 | 82 |
GSM687702 | Patient 443 treated 4 weeks | 409.803 | 59 |
GSM687718 | Patient 449 treated 4 weeks | 639.021 | 68 |
GSM687723 | Patient 450 treated 4 weeks | 1325.3 | 78 |
GSM687661 | Patient 404 treated 4h | 11632.6 | 98 |
GSM687710 | Patient 448 treated 4h | 1633.25 | 81 |
GSM687726 | Patient 451 treated 4h | 983.53 | 74 |
GSM687730 | Patient 452 treated 4h | 209.834 | 34 |
GSM687660 | Patient 404 treated 24h | 30109.2 | 99 |
GSM687697 | Patient 441 treated 24h | 3006.78 | 89 |
GSM687709 | Patient 448 treated 24h | 2667.95 | 87 |
GSM687725 | Patient 451 treated 24h | 827.26 | 71 |
GSM687729 | Patient 452 treated 24h | 270.983 | 49 |
GSM687727 | Patient 451 treated 4 weeks | 1614.78 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 7496.51 | 96 |